Europe Lipidomics Equipment Market is expected to reach US$ 692.03 million by 2028

At 14.9% CAGR, the Europe Lipidomics Equipment Market is speculated to be worth US$ 692.03 million by 2028, says Business Market Insights 

According to Business Market Insights’ research, the Europe lipidomics equipment market was valued at US$ 301.13 million in 2022 and is expected to reach US$ 692.03 million by 2028, registering a CAGR of 14.9% from 2022 to 2028. Growing applications of lipidomics in biomedical sciences and technological advancements in mass spectrometry are the critical factors attributed to the Europe lipidomics equipment market expansion.                  

Mass spectrometers are commonly used for the identification and quantification of lipids. The high-energy collisional-activated dissociation (CAD) technique of mass spectrometry results in charge remote fragmentation (CRF) reactions, which help detect the location of small structural bond details. Several advanced mass spectrometers, including sector mass spectrometry, matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF), liquid chromatography-mass spectrometry (LC-MS), and tandem mass spectrometer have been made available for researchers and technicians. Further, these instruments are being integrated with automation, miniaturization, artificial intelligence (AI), and smart technologies to enhance their efficiencies and accuracies. In 2018, Thermo Scientific launched Genesys 50 UV/vis spectrometer that has a single cell configuration for low sample throughput needs, with a removable, washable sampling compartment for easy clean-up. In the same year, Shimadzu, in collaboration with PREMIER Biosoft, launched Shimadzu's LCMS-9030 Quadrupole Time of Flight (Q-TOF) mass spectrometry (MS) system for lipidomics and glycomics data analysis; the product features informatics support powered by software solutions of PREMIER Biosoft. Therefore, the introduction of such new enhanced mass spectrometers and micropumps is boosting the growth of the Europe lipidomics equipment market.     

On the contrary, premium product pricing hurdles the growth of Europe lipidomics equipment market.   

Based on type, the Europe lipidomics equipment market is bifurcated into targeted and untargeted. The targeted segment held 62.5% market share in 2022, amassing US$ 188.06 million. It is projected to garner US$ 429.13 million by 2028 to expand at 14.7% CAGR during 2022–2028.   

Based on offerings, the Europe lipidomics equipment market is segmented into MS-based lipidomics techniques, assays for lipid metabolism, lipid flux using heavy isotope-labeled precursors, software & services, and others. The MS-based lipidomics techniques segment held 66.3% share of Europe lipidomics equipment market in 2022, amassing US$ 199.73 million. It is projected to garner US$ 457.16 million by 2028 to expand at 14.8% CAGR during 2022–2028. The MS-based lipidomics techniques segment is further categorized into mass spectrometers equipped with ion sources (turbo-) ESI/nano-ESI/APCI, autosamplers, micropumps, UV detectors, UPLC, variable-length fluorescence detectors, and others.    

Based on services, the Europe lipidomics equipment market has been segmented into biomarker identification, bioinformatic analysis & data interpretation, molecular analysis of a broad spectrum of phospholipids (lipid fingerprinting), analysis & identification of unusual lipids, semiquantitative & quantitative analysis, lipid flux studies, and others. The biomarker identification segment held 29.8% share of Europe lipidomics equipment market in 2022, amassing US$ 89.72 million. It is projected to garner US$ 205.35 million by 2028 to expand at 14.8% CAGR during 2022–2028.       

Based on end user, the Europe lipidomics equipment market is segmented into molecular research, cellular research, clinical research, tissue & organ research, data research, organism research, technical services & prototyping, production, and others. The molecular research segment held 27.3% share of Europe lipidomics equipment market in 2022, amassing US$ 82.11 million. It is projected to garner US$ 190.18 million by 2028 to expand at 15.0% CAGR during 2022–2028.              

Based on country, the Europe lipidomics equipment market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that the Rest of Europe captured 28.0% share of Europe lipidomics equipment market in 2022. It was assessed at US$ 84.43 million in 2022 and is likely to hit US$ 188.44 million by 2028, exhibiting a CAGR of 14.3% during the forecast period.         

Key players dominating the Europe lipidomics equipment market are Agilent Technologies, Inc.; Bruker; Cayman Chemical; Creative Proteomics; IonBench; Metabolon, Inc.; PerkinElmer Inc.; Sciex; Shimadzu Corporation.; and Thermo Fisher Scientific Inc., among others.  

• In Sep 2021, Thermofisher Scientific launched new Vanish Neo UHPLC System which will transform how scientists perform proteomics studies by providing the long-term robustness and flow-range versatility required for deep and fast LC-MS profiling of thousands of proteomes, while coupled with PepMap Columns and high-resolution accurate mass (HRAM) systems. The new Thermo Scientific Vanquish Neo UHPLC System and Thermo Scientific PepMap Neo Columns deliver application flexibility and robust analytical performance at flow rates from 1nL/min to 100µL/min up to 1500 bar. Novice and expert LC-MS users will enjoy accelerated productivity, reduced method overhead time and long-term operation essential for 24/7 large sample cohort analysis.  

Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: sam@businessmarketinsights.com